RT Book, Section
A1 Berrios, Ricardo L.
A1 Bonner, Michael Y.
A1 Hofmekler, Jonathan
A1 Arbiser, Jack L.
A2 Goldsmith, Lowell A.
A2 Katz, Stephen I.
A2 Gilchrest, Barbara A.
A2 Paller, Amy S.
A2 Leffell, David J.
A2 Wolff, Klaus
SR Print(0)
ID 56102487
T1 Chapter 235. Antiangiogenic Agents
T2 Fitzpatrick's Dermatology in General Medicine, 8e
YR 2012
FD 2012
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-166904-7
LK accessmedicine.mhmedical.com/content.aspx?aid=56102487
RD 2024/04/25
AB |PrintAntiangiogenic  Agents  at  a  Glance“Direct”  antiangiogenic  agents  act  directly  on  untransformed  endothelial  cells  to  prevent  proliferation,  migration,  and  survival.“Indirect”  antiangiogenic  agents  inhibit  tumor-produced  oncogene  proteins  that  promote  a  proangiogenic  state.Antiangiogenic  agents  are  a  promising  class  of  drugs  because  they  are  effective  against  slow-growing  tumors.